Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mizuguchi

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Gene Therapy|October 17, 2008
Effect of therapeutic immunization using Ad5/35 and MVA vectors on SIV infection of rhesus monkeys undergoing antiretroviral therapyM Shimada, H-B Wang, A Kondo, et al.
Die Pharmazie|April 13, 2004
Tumor-suppressive activities by chemokines introduced into OV-HM cells using fiber-mutant adenovirus vectorsJ Q Gao, L S Alexandre, Y Tsuda, et al.
Molecular Membrane Biology|May 20, 1999
Gene delivery systems using the Sendai virusM Nakanishi, H Mizuguchi, K Ashihara, et al.
Gene Therapy|August 5, 2005
Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIVK-Q Xin, N Jounai, K Someya, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancerJ A Ajani, M Abramov, I Bondarenko, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Gene Therapy|October 17, 2008
Effect of therapeutic immunization using Ad5/35 and MVA vectors on SIV infection of rhesus monkeys undergoing antiretroviral therapyM Shimada, H-B Wang, A Kondo, et al.
Die Pharmazie|April 13, 2004
Tumor-suppressive activities by chemokines introduced into OV-HM cells using fiber-mutant adenovirus vectorsJ Q Gao, L S Alexandre, Y Tsuda, et al.
Molecular Membrane Biology|May 20, 1999
Gene delivery systems using the Sendai virusM Nakanishi, H Mizuguchi, K Ashihara, et al.
Gene Therapy|August 5, 2005
Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIVK-Q Xin, N Jounai, K Someya, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancerJ A Ajani, M Abramov, I Bondarenko, et al.
Pageof 14